Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2025-03-13 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
海通证券股份有限公司关于和元生物技术（上海）股份有限公司首次公开发行部分限售股上市流通的核查意见
Regulatory Filings
2025-03-13 Chinese
关于首次公开发行部分限售股上市流通公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from a company regarding the listing and circulation of restricted shares following an initial public offering (IPO). It details the number of shares becoming freely tradable, the lock-up period expiration, shareholder commitments, and regulatory compliance confirmations. The content focuses on the unlocking and circulation of restricted shares post-IPO, including shareholder commitments and regulatory approvals. This type of document is a formal announcement about share circulation and lock-up expiration, not a financial report or earnings release. It fits the category of Share Issue/Capital Change (SHA) because it concerns the change in share capital availability due to restricted shares becoming tradable.
2025-03-13 Chinese
关于5%以上股东权益变动触及1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a change in significant shareholding, specifically a shareholder reducing their stake by more than 1% increments. It details the shareholder names, shareholding percentages before and after the change, and confirms no change in control or governance. The document references regulatory disclosure requirements for shareholding changes crossing 1% thresholds. There is no financial report, earnings data, or management discussion. The content matches the definition of a Major Shareholding Notification, which involves reporting changes in significant share ownership levels crossing thresholds.
2025-03-06 Chinese
关于股份回购进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company regarding the progress of its share repurchase program. It details the board approval of the repurchase plan, the intended use of repurchased shares, the repurchase price limits, and the current status of the repurchase (no shares repurchased yet). It references regulatory rules about share repurchases and states the company will disclose progress monthly. The document is short (1179 characters) and focuses on the update of share buyback activity rather than presenting financial statements or detailed financial data. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares (share repurchase/issuance).
2025-03-04 Chinese
关于2024年度计提资产减值准备及预计负债的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by the company about the 2024 fiscal year asset impairment provisions and expected liabilities. It details the amounts and types of impairment losses and provisions the company has made, including credit impairment losses, inventory write-downs, long-term asset impairments, and expected liabilities. The document states these are preliminary accounting estimates subject to final audit confirmation. It does not contain full financial statements or comprehensive financial performance data but rather a specific accounting provision update. The document length is 1868 characters, which is relatively short and focused on a specific accounting matter rather than a full report. This fits best under a Regulatory Filing (RNS) as it is a regulatory announcement about accounting estimates and provisions, not a full Annual Report (10-K) or Interim Report (IR).
2025-02-26 Chinese
2024年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2024 年度业绩快报公告" which translates to "2024 Annual Performance Express Report Announcement." It contains preliminary financial data for the full year 2024, including revenue, profit, net income, earnings per share, and asset information. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be in the 2024 Annual Report. The document is relatively short (2440 characters) and serves as a quick earnings update rather than a full comprehensive report. It does not contain full financial statements or detailed analysis typical of an Annual Report (10-K) or Interim Report (IR). It is also not a simple announcement of report publication but a brief financial performance summary. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. FY 2024
2025-02-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.